Skip to the page

Data / Drug companies / Prednisolone sodium phosphate

Prednisolone sodium phosphate: 16 companies and 29 products in the FDA NDC directory

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Prednisolone sodium phosphate is listed in the FDA National Drug Code Directory by 16 companies, with 29 products in commercial distribution. 21 of the products (72.4%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are solution; tablet, orally disintegrating; solution/ drops, and the newest product started marketing on June 26, 2026.

The request: Get every company that lists prednisolone sodium phosphate in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Companies listing it
16
Products
29
Generic (ANDA) products
21 (72.4%)
Application numbers
10
Routes
Oral, Ophthalmic
Brand names
Orapred Odt
openFDA record search
api.fda.gov

Companies that list prednisolone sodium phosphate

Ranked by number of products. Finished drugs in commercial distribution.

CompanyProductsMain dosage formsMain marketing categoryNewest product started
Pai Holdings, LLC DBA Pai Pharma5solutionGeneric drugs (ANDA)June 26, 2026
Edenbridge Pharmaceuticals LLC.4solutionGeneric drugs (ANDA)October 9, 2023
Advanz Pharma (US) Corp.3tablet, orally disintegratingNew drug applications (NDA)June 1, 2006
Ingenus Pharmaceuticals, LLC3tablet, orally disintegratingAuthorized generics (NDA)September 15, 2025
Atlantic Biologicals Corp.2solutionGeneric drugs (ANDA)October 9, 2023
Preferred Pharmaceuticals Inc.2solutionGeneric drugs (ANDA)October 28, 2025
A-S Medication Solutions1solutionGeneric drugs (ANDA)April 25, 2005
Amneal Pharmaceuticals NY LLC1solutionGeneric drugs (ANDA)October 27, 2022
Bausch & Lomb Incorporated1solution/ dropsGeneric drugs (ANDA)July 29, 1994
BioComp Pharma, Inc.1solutionGeneric drugs (ANDA)October 28, 2019
Chartwell Governmental & Specialty RX, LLC.1solutionGeneric drugs (ANDA)May 25, 2004
Chartwell RX, LLC1solutionGeneric drugs (ANDA)May 25, 2004
Proficient Rx LP1solutionGeneric drugs (ANDA)April 25, 2005
Redpharm Drug1solutionGeneric drugs (ANDA)October 9, 2023
Remedyrepack Inc.1solutionGeneric drugs (ANDA)November 28, 2025
Seton Pharmaceuticals1solutionNew drug applications (NDA)October 18, 2013

Dosage forms

Dosage formProductsShare
Solution2275.9%
Tablet, orally disintegrating620.7%
Solution/ drops13.4%

Marketing categories

Marketing categoryProductsShare
Generic drugs (ANDA)2172.4%
New drug applications (NDA)517.2%
Authorized generics (NDA)310.3%

Pharmacologic classes

ClassProducts
Corticosteroid29

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.